tiprankstipranks
Trending News
More News >
Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
US Market

Boundless Bio Inc. (BOLD) Ratios

Compare
36 Followers

Boundless Bio Inc. Ratios

BOLD's free cash flow for Q3 2025 was $―. For the 2025 fiscal year, BOLD's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
14.08 13.27 8.80 19.28-
Quick Ratio
14.08 13.27 8.80 19.28-
Cash Ratio
1.60 2.53 1.42 8.87-
Solvency Ratio
-1.11 -0.19 -0.28 -0.16-
Operating Cash Flow Ratio
-5.99 -5.01 -5.12 -6.01-
Short-Term Operating Cash Flow Coverage
-28.14 0.00 0.00 0.00-
Net Current Asset Value
$ 72.93M$ -132.77M$ -90.49M$ -77.34M-
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.02 0.07 <0.01-
Debt-to-Equity Ratio
0.40 -0.02 -0.06 >-0.01-
Debt-to-Capital Ratio
0.29 -0.02 -0.07 >-0.01-
Long-Term Debt-to-Capital Ratio
0.28 0.00 0.00 0.00-
Financial Leverage Ratio
1.46 -1.02 -0.94 -2.98-
Debt Service Coverage Ratio
-31.22 0.00 0.00 0.00-
Interest Coverage Ratio
0.00 0.00 0.00 0.00-
Debt to Market Cap
1.99 0.00 0.00 0.00-
Interest Debt Per Share
2.21 0.10 0.23 0.02-
Net Debt to EBITDA
-0.57 0.44 0.13 1.38-
Profitability Margins
Gross Profit Margin
-34.85%0.00%0.00%0.00%-
EBIT Margin
-5731.25%0.00%0.00%0.00%-
EBITDA Margin
-5798.30%0.00%0.00%0.00%-
Operating Profit Margin
-6760.89%0.00%0.00%0.00%-
Pretax Profit Margin
-6097.54%0.00%0.00%0.00%-
Net Profit Margin
-6097.54%0.00%0.00%0.00%-
Continuous Operations Profit Margin
-6097.54%0.00%0.00%0.00%-
Net Income Per EBT
100.00%100.00%100.00%100.00%-
EBT Per EBIT
90.19%90.21%98.78%99.64%-
Return on Assets (ROA)
-35.88%-38.06%-59.74%-22.17%-
Return on Equity (ROE)
-44.79%38.90%56.19%66.01%-
Return on Capital Employed (ROCE)
-41.94%-45.46%-67.25%-23.03%-
Return on Invested Capital (ROIC)
-41.46%-44.65%-64.10%-22.87%-
Return on Tangible Assets
-35.88%-38.06%-59.74%-22.17%-
Earnings Yield
-259.48%-22228184.63%-20639557.85%-1.89%-
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00-
Payables Turnover
0.52 0.43 0.67 0.63-
Inventory Turnover
0.00 0.00 0.00 0.00-
Fixed Asset Turnover
0.02 0.00 0.00 0.00-
Asset Turnover
<0.01 0.00 0.00 0.00-
Working Capital Turnover Ratio
<0.01 0.00 0.00 0.00-
Cash Conversion Cycle
-702.44 -847.47 -543.24 -575.33-
Days of Sales Outstanding
0.00 0.00 0.00 0.00-
Days of Inventory Outstanding
0.00 0.00 0.00 0.00-
Days of Payables Outstanding
702.44 847.47 543.24 575.33-
Operating Cycle
0.00 0.00 0.00 0.00-
Cash Flow Ratios
Operating Cash Flow Per Share
-2.47 -2.11 -1.78 -1.05-
Free Cash Flow Per Share
-2.52 -2.14 -1.83 -1.14-
CapEx Per Share
0.05 0.03 0.05 0.09-
Free Cash Flow to Operating Cash Flow
1.02 1.01 1.03 1.09-
Dividend Paid and CapEx Coverage Ratio
-52.26 -74.02 -37.14 -11.43-
Capital Expenditure Coverage Ratio
-52.26 -74.02 -37.14 -11.43-
Operating Cash Flow Coverage Ratio
-1.11 -21.35 -7.64 -61.67-
Operating Cash Flow to Sales Ratio
-52.26 0.00 0.00 0.00-
Free Cash Flow Yield
-226.35%-21353158.39%-18283821.73%-1.90%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.39 >-0.01 >-0.01 -52.90-
Price-to-Sales (P/S) Ratio
23.53 0.00 0.00 0.00-
Price-to-Book (P/B) Ratio
0.20 >-0.01 >-0.01 -34.92-
Price-to-Free Cash Flow (P/FCF) Ratio
-0.44 >-0.01 >-0.01 -52.75-
Price-to-Operating Cash Flow Ratio
-0.45 >-0.01 >-0.01 -57.37-
Price-to-Earnings Growth (PEG) Ratio
-0.17 >-0.01 >-0.01 0.00-
Price-to-Fair Value
0.20 >-0.01 >-0.01 -34.92-
Enterprise Value Multiple
-0.97 0.44 0.13 -52.80-
Enterprise Value
59.66M -21.51M -5.77M 1.30B-
EV to EBITDA
-0.97 0.44 0.13 -52.80-
EV to Sales
56.50 0.00 0.00 0.00-
EV to Free Cash Flow
-1.06 0.45 0.14 -51.41-
EV to Operating Cash Flow
-1.08 0.46 0.15 -55.91-
Tangible Book Value Per Share
5.49 -5.71 -3.67 -1.72-
Shareholders’ Equity Per Share
5.49 -5.71 -3.67 -1.72-
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.01 <0.01-
Revenue Per Share
0.05 0.00 0.00 0.00-
Net Income Per Share
-2.88 -2.22 -2.06 -1.13-
Tax Burden
1.00 1.00 1.00 1.00-
Interest Burden
1.06 1.00 1.00 1.00-
Research & Development to Revenue
48.71 0.00 0.00 0.00-
SG&A to Revenue
18.59 0.00 0.00 0.00-
Stock-Based Compensation to Revenue
7.14 0.00 0.00 0.00-
Income Quality
0.86 0.95 0.86 0.92-
Currency in USD